Status:
RECRUITING
Hemp Seed Awareness
Lead Sponsor:
University Hospital, Angers
Conditions:
Allergy
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
Hemp is a plant of the Cannabaceae family. Cannabis sativa, derived from female flowers, is the first illicit substance used by adolescents and is a major public health problem. Its psycho-active effe...
Eligibility Criteria
Inclusion
- Major patient
- Patient referred to the Allergology Unit of the Hospital of Angers, in consultation or in Hospitalization - for conducting prick-tests
- Patient affiliated or beneficiary of a social security scheme
- Patient with informed consent
Exclusion
- Pregnant women, parturients
- Persons deprived of liberty by administrative or judicial decision
- Persons receiving psychiatric care under duress
- Adults under legal protection measure
- People out of state to express consent
- people not able to understand French language
- Patients whose skin reactivity prevents interpretation of tests (patients who cannot interrupt anti-histamines or have severe eczema)
Key Trial Info
Start Date :
June 1 2021
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
May 31 2025
Estimated Enrollment :
600 Patients enrolled
Trial Details
Trial ID
NCT04841954
Start Date
June 1 2021
End Date
May 31 2025
Last Update
June 11 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
MORISSET Martine
Angers, France